Open grant

Immune Tolerance Network (UM1 Clinical Trial Required)

From	National Institutes of Health
Who can apply	state governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types
Eligibility notes	Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S.
How much	about 1 award; $22 million total
Deadline	Fri, Jan 29, 2027 (98 days left)
Category	Health
Type	Cooperative agreement
Opportunity #	RFA-AI-28-005
Assistance listing	93.855
Posted	Tue, Oct 20, 2026

Open the official posting

From the notice

The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.